Vanda Pharmaceuticals, Inc. (VNDA) Posts Wider than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.25 -1.5%
EPS Growth %: -60.5%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -60.5%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q3 EPS of ($0.11), $0.03 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.26 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- American Eagle Outfitters (AEO) Tops Q2 EPS by 57c
- Signet shares jump on Q2 profit beat, raised annual guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
